| For: | Kurdi M, Mulla N, Malibary H, Bamaga AK, Fadul MM, Faizo E, Hakamy S, Baeesa S. Immune microenvironment of medulloblastoma: The association between its molecular subgroups and potential targeted immunotherapeutic receptors. World J Clin Oncol 2023; 14(3): 117-130 [PMID: 37009528 DOI: 10.5306/wjco.v14.i3.117] |
|---|---|
| URL: | https://www.wjgnet.com/2218-4333/full/v14/i3/117.htm |
| Number | Citing Articles |
| 1 |
Tang-Her Jaing, Yi-Lun Wang, Chia-Chi Chiu. Immune Checkpoint Inhibitors for Pediatric Cancers: Is It Still a Stalemate?. Pharmaceuticals 2024; 17(8) doi: 10.3390/ph17080991
|
| 2 |
Serge Yaacoub, Elton Vannoy, Stefanyda Maslova, Abigail Haffey, Khatereh Khorsandi, Natasha Sheybani, Dalia Haydar. CAR-T cell therapy in brain malignancies: obstacles in the face of cellular trafficking and persistence. Frontiers in Immunology 2025; 16 doi: 10.3389/fimmu.2025.1596499
|
| 3 |
Mengyuan Li, Jihong Peng, Chun Chen, Jinyang Hu. Decoding the immune microenvironment: precision immunotherapy for medulloblastoma subtypes. Frontiers in Immunology 2026; 17 doi: 10.3389/fimmu.2026.1714134
|
| 4 |
Christian Bittner, Shankar Ganapathy, Jennifer Baccon. Educational Case: Medulloblastoma. Academic Pathology 2026; 13(4) doi: 10.1016/j.acpath.2026.100283
|
| 5 |
Motaz Fadul, Saleh Baeesa, Alaa Alkhotani, Amany A. Fathaddin, Ahmed I. Lary, Bassam Addass, Taghreed Alsinani, Ahmed Bamaga, Ahmad Albeshri, Mohammed M. Karami, Mohammed A. Abutalib, Maher Kurdi. Exploring IDH1 and IDH2 Mutations in Paediatric Medulloblastoma. Folia Biologica 2025; 71(2) doi: 10.14712/fb2025071020073
|
| 6 |
Shuaishuai Xue, Zhengming Zhan, Yonghua Cai, Wei Chen, Ruizhe Chen, Yangqi Mao, Cheng Xie, Jun Liu, Ziyi Luo, Siyuan Liu, Xian Zhang, Peng Li, Hao Long, Ye Song. PCK2 as a potential therapeutic target for aggressive MYC-amplified non-WNT/non-SHH medulloblastoma based on tumor continuum. Acta Neuropathologica Communications 2026; 14(1) doi: 10.1186/s40478-026-02304-z
|
| 7 |
Julian S. Rechberger, Stephanie A. Toll, Wouter J. F. Vanbilloen, David J. Daniels, Soumen Khatua. Exploring the Molecular Complexity of Medulloblastoma: Implications for Diagnosis and Treatment. Diagnostics 2023; 13(14) doi: 10.3390/diagnostics13142398
|
| 8 |
Caroline Donze, Patricia Piris, Pierre Leblond, Mélanie Matteudi, Eddy Pasquier, Manon Carre, Nicolas Andre. Building a new arsenal: repurposed drugs and metronomic chemotherapy against medulloblastoma. Expert Review of Neurotherapeutics 2026; 26(3) doi: 10.1080/14737175.2026.2625847
|
| 9 |
Roghaye Keshavarz Sadegh, Kiarash Saleki, Nima Rezaei. Immune checkpoint inhibitor (ICI) therapy in central nervous system cancers: State-of-the-art and future outlook. International Immunopharmacology 2025; 159 doi: 10.1016/j.intimp.2025.114837
|
| 10 |
Yunpeng Hu. Albiflorin suppresses breast cancer via the HINT2/NLRP3 signaling pathway. Pakistan Journal of Pharmaceutical Sciences 2026; doi: 10.36721/PJPS.2026.39.12.348.1
|